Insider Transactions Reported by 19 Insiders of CytomX Therapeutics, Inc.

Symbol
CTMX on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

CytomX Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sean A. McCarthy CEO, Director $9,982,620 -$633,726 -6% 02 Feb 2026
MARCIA BELVIN SVP, Chief Scientific Officer $1,415,393 -$49,022 -3.3% 02 Feb 2026
Christopher Ogden Chief Financial Officer $1,347,314 -$38,503 -2.8% 02 Feb 2026
Yu-Waye Chu Chief Medical Officer $897,688 -$2,411 -0.27% 02 Feb 2026
Jeffrey B. Landau Chief Business Officer $155,772 20 Aug 2024
Rachael Lester Chief Business Officer $85,200 02 Feb 2026
Amy C. Peterson EVP, Chief Development Officer $80,678 16 Mar 2023
LLOYD A. ROWLAND General Counsel $72,236 -$6,112 -7.8% 18 Mar 2025
Carlos Campoy Chief Financial Officer $52,776 16 Mar 2023
ALISON L. HANNAH Chief Medical Officer $44,042 19 Jul 2022
Halley E. Gilbert Director 11 Jun 2025
Zhen Su Director 11 Jun 2025
John A. Scarlett Director 16 Jun 2021
Elaine Jones V. Director 11 Jun 2025
James R. Meyers Director 11 Jun 2025
Alan Ashworth Director 11 Jun 2025
Mani Mohindru Director 11 Jun 2025
Matthew P. Young Director 11 Jun 2025
FREDERICK W. GLUCK Director 15 Jun 2022

Recent Insider Transactions by Companies or Individuals for CytomX Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.